Correspondence to proton pump inhibitors and risk of colorectal cancer
Gut
.
2022 Aug;71(8):1690.
doi: 10.1136/gutjnl-2021-326139.
Epub 2021 Dec 2.
Authors
Chen Dong
1
,
Yun-Hsun Lee
1
,
Tzu-Yang Tan
1
,
Chung-Chin Yao
2
,
James Cheng-Chung Wei
3
4
5
6
Affiliations
1
School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
2
Division of General Surgery, Department of Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan.
3
Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan jccwei@gmail.com.
4
Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
5
Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
6
Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
PMID:
34857615
DOI:
10.1136/gutjnl-2021-326139
No abstract available
Keywords:
colorectal cancer; proton pump inhibition.
Publication types
Letter
Comment
MeSH terms
Colorectal Neoplasms* / chemically induced
Humans
Proton Pump Inhibitors* / adverse effects
Risk Factors
Substances
Proton Pump Inhibitors